175 related articles for article (PubMed ID: 19696786)
1. Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells.
Romano S; D'Angelillo A; Pacelli R; Staibano S; De Luna E; Bisogni R; Eskelinen EL; Mascolo M; Calì G; Arra C; Romano MF
Cell Death Differ; 2010 Jan; 17(1):145-57. PubMed ID: 19696786
[TBL] [Abstract][Full Text] [Related]
2. FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.
Romano S; Xiao Y; Nakaya M; D'Angelillo A; Chang M; Jin J; Hausch F; Masullo M; Feng X; Romano MF; Sun SC
Nucleic Acids Res; 2015 Aug; 43(14):6983-93. PubMed ID: 26101251
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of large immunophilin FK506 binding protein 51 in cancer.
Romano S; Sorrentino A; Di Pace AL; Nappo G; Mercogliano C; Romano MF
Curr Med Chem; 2011; 18(35):5424-9. PubMed ID: 22087835
[TBL] [Abstract][Full Text] [Related]
4. FKBP51 protects 661w cell culture from staurosporine-induced apoptosis.
Daudt DR; Yorio T
Mol Vis; 2011; 17():1172-81. PubMed ID: 21617754
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis.
Srivastava SK; Bhardwaj A; Arora S; Tyagi N; Singh AP; Carter JE; Scammell JG; Fodstad Ø; Singh S
Br J Cancer; 2015 May; 112(11):1772-81. PubMed ID: 25942396
[TBL] [Abstract][Full Text] [Related]
6. FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.
Romano S; Staibano S; Greco A; Brunetti A; Nappo G; Ilardi G; Martinelli R; Sorrentino A; Di Pace A; Mascolo M; Bisogni R; Scalvenzi M; Alfano B; Romano MF
Cell Death Dis; 2013 Apr; 4(4):e578. PubMed ID: 23559012
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells.
Romano MF; Avellino R; Petrella A; Bisogni R; Romano S; Venuta S
Eur J Cancer; 2004 Dec; 40(18):2829-36. PubMed ID: 15571967
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens.
Park J; Kim M; Na G; Jeon I; Kwon YK; Kim JH; Youn H; Koo Y
Mol Cell Endocrinol; 2007 Nov; 278(1-2):7-17. PubMed ID: 17870233
[TBL] [Abstract][Full Text] [Related]
9. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans.
Gassen NC; Hartmann J; Zschocke J; Stepan J; Hafner K; Zellner A; Kirmeier T; Kollmannsberger L; Wagner KV; Dedic N; Balsevich G; Deussing JM; Kloiber S; Lucae S; Holsboer F; Eder M; Uhr M; Ising M; Schmidt MV; Rein T
PLoS Med; 2014 Nov; 11(11):e1001755. PubMed ID: 25386878
[TBL] [Abstract][Full Text] [Related]
10. Molecular Aspects of FKBP51 that Enable Melanoma Dissemination.
D'Angelillo A; Staibano S; Russo M; Romano MF; Romano S
Curr Mol Pharmacol; 2015; 9(2):141-7. PubMed ID: 25986563
[TBL] [Abstract][Full Text] [Related]
11. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
12. Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.
Mascolo M; Romano MF; Ilardi G; Romano S; Baldo A; Scalvenzi M; Argenziano G; Merolla F; Russo D; Varricchio S; Pagliuca F; Russo M; Ciancia G; De Rosa G; Staibano S
J Eur Acad Dermatol Venereol; 2018 May; 32(5):735-744. PubMed ID: 28977697
[TBL] [Abstract][Full Text] [Related]
13. TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-α inhibition.
Romano S; D'Arrigo P; Tufano M; Staibano S; Rea A; Merolla F; Ilardi G; Petrella A; Romano MF
Melanoma Res; 2019 Apr; 29(2):145-150. PubMed ID: 30451787
[TBL] [Abstract][Full Text] [Related]
14. FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action.
Gassen NC; Hartmann J; Schmidt MV; Rein T
Autophagy; 2015; 11(3):578-80. PubMed ID: 25714272
[TBL] [Abstract][Full Text] [Related]
15. FKBP51 and the NF-κB regulatory pathway in cancer.
Romano S; Mallardo M; Romano MF
Curr Opin Pharmacol; 2011 Aug; 11(4):288-93. PubMed ID: 21565553
[TBL] [Abstract][Full Text] [Related]
16. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J
Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of FKBP51 in human cancers.
Staibano S; Mascolo M; Ilardi G; Siano M; De Rosa G
Curr Opin Pharmacol; 2011 Aug; 11(4):338-47. PubMed ID: 21530399
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP.
Thayaparasingham B; Kunz A; Peters N; Kulms D
Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816
[TBL] [Abstract][Full Text] [Related]
19. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.
Komura E; Tonetti C; Penard-Lacronique V; Chagraoui H; Lacout C; Lecouédic JP; Rameau P; Debili N; Vainchenker W; Giraudier S
Cancer Res; 2005 Apr; 65(8):3281-9. PubMed ID: 15833861
[TBL] [Abstract][Full Text] [Related]
20. The Many Faces of FKBP51.
Hähle A; Merz S; Meyners C; Hausch F
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
